HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
RecruitingPhase 1
Who can join
Ages 50 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * HIV+ * have visited a local VA site in within the past year * had an AUDIT-C indicating current alcohol use * taking 5 or more non-ART medications, including an NCAM (i.e., benzodiazepines, opioids, muscle relaxants, sleeping medication, and selective serotonin reuptake inhibitors) Exclusion Criteria: * Inpatient individuals * Patients with an Alcohol Use Disorder (AUD) diagnosis in the past 12 months * Patients who test positive on the Alcohol Symptom Checklist for moderate or severe AUD during the screening process
About the study
The focus of this pilot will be on falls and neurocognitive symptoms, and the impact of alcohol, cannabis use, and medications on these outcomes. The rationale is that alcohol use at any level may interact with neurocognitively active medications, alcohol, and cannabis use leading to falls and impaired cognition.
What is being tested
- Information Motivation Behavioral and Motivational Interviewing (IMB-MI) technique (behavioral)
Sponsor: Yale University · Participants: 100 · Started: Jan 15, 2025
Contact the study team
- Amy C Justice, MD, PhD · Phone: 203-932-5711
Official record on ClinicalTrials.gov — NCT06513819
Locations in the U.S.
| Connecticut | VA Connecticut Healthcare System, West Haven |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.